Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council-Reference-Cited by-同舟云学术

Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council

Published:2020-12 Issue:2 Volume:1 Page:224-230
ISSN:2666-3287
Container-title:JAAD International
language:en
Short-container-title:JAAD International

Author:

Cohen Arnon D.,Vender Ronald,Naldi Luigi,Kalb Robert E.,Torres Tiago,Rajagopalan Murlidhar,van der Walt Joelle,Puig Lluís,Young Helen S.

Funder

Janssen

Novartis

AbbVie

Sanofi

Amgen

Janssen-Ortho

UCB

Almirall

Arena Pharmaceuticals

Biocad

Boehringer Ingelheim

Bristol-Myers Squibb

Celgene

Eli Lilly

Leo Pharma

MSD

Pfizer

Samsung-Bioepis

Sandoz

Lilly

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Biosimilar drugs for psoriasis: principles, present, and near future;Carrascosa;Dermatol Ther (Heidelb),2018

2. Safety, efficacy and drug survival of biologics and biosimilars for moderate- to-severe plaque psoriasis;Egeberg;Br J Dermatol,2018

3. Old and new biological therapies for psoriasis;Rønholt;Int J Mol Sci,2017

4. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis;Sbidian;Cochrane Database Syst Rev,2017

5. Anti-TNF biosimilars in psoriasis: from scientific evidence to real-world experience;Barker;J Dermatolog Treat,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, double-blind, phase III study assessing clinical similarity of SB17 (proposed ustekinumab biosimilar) to reference ustekinumab in subjects with moderate-to-severe plaque psoriasis;Journal of the American Academy of Dermatology;2024-09

2. ‘I don't know which is the chicken and which is the egg’: A qualitative study of weight loss‐related beliefs and behaviours among adults with psoriasis and comorbid obesity;British Journal of Health Psychology;2022-12-09

3. Cost-effectiveness analysis of biological drugs in treating moderate to severe plaque psoriasis from the perspective of a health service provider;Klinická farmakologie a farmacie;2022-07-07

4. The importance of illness severity and multimorbidity in the association between mental health and body weight in psoriasis: Cross‐sectional and longitudinal analysis;Skin Health and Disease;2022-04-19